A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease

M Sano, C Ernesto, RG Thomas… - … England Journal of …, 1997 - Mass Medical Soc
Background There is evidence that medications or vitamins that increase the levels of brain
catecholamines and protect against oxidative damage may reduce the neuronal damage …
被引用次数：3495 相关文章

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

M Sano, C Ernesto, RG Thomas… - The New England …, 1997 - pubmed.ncbi.nlm.nih.gov
Background There is evidence that medications or vitamins that increase the levels of brain
catecholamines and protect against oxidative damage may reduce the neuronal damage …

[引用][C] A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease

M SANO, C ERNESTO… - The New England …, 1997 - pascal-francis.inist.fr
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

M Sano, C Ernesto, RG Thomas… - The New England …, 1997 - europepmc.org
Background There is evidence that medications or vitamins that increase the levels of brain
catecholamines and protect against oxidative damage may reduce the neuronal damage …

[引用][C] A controlled trial of selegiline alpha-tocoherol, or both as treatment for Alzheimer's disease

M SANO - N Engl Med, 1997 - cir.nii.ac.jp
A controlled trial of selegiline alpha-tocoherol, or both as treatment for Alzheimer's disease |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease.

M Sano, C Ernesto, RG Thomas… - The New England …, 1997 - psycnet.apa.org
Conducted a double-blind, placebo-controlled, randomized, multicenter trial in patients with
Alzheimer's disease (AD) of moderate severity. A total of 341 patients received the selective …

[引用][C] A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

M SANO - N Engl J Med, 1997 - cir.nii.ac.jp
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease.
The Alzheimer's Disease Cooperative Study | CiNii Research CiNii 国立情報学研究所 学術 …

[引用][C] A CONTROLLED TRIAL OF SELEGILINE, ALPHA-TOCOPHEROL, OR BOTH AS TREATMENT FO ALZHEIMER'S DISEASE

M SANO, C ERNESTO, RG THOMAS - 1997 - sid.ir

[引用][C] A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease

M SANO, C ERNESTO… - The New …, 1997 - Massachusetts Medical Society